Table 1.

Baseline patient characteristics by MRD status of patients randomly assigned to IR and tested successfully for MRD

Variable/categoryMRDMRD+TotalP
Patients, n 38 252 290 – 
Age     
 Mean (SD) 56.4 (7.0) 56.3 (7.4) 56.3 (7.3) .879 
 Median (Q1, Q3) 57.5 (54.0, 60.8) 57.0 (51.8, 62.0) 57.0 (52.0, 62.0)  
 [Min, max] [35.0, 67.0] [31.0, 70.0] [31.0, 70.0]  
 Freq. of missing  
Age, category     
 <60 25 (65.8) 157 (62.3) 182 (62.8) .723 
 ≥60 13 (34.2) 95 (37.7) 108 (37.2)  
 Unknown/missing  
Sex     
 Female 13 (34.2) 83 (32.9) 96 (33.1) .855 
 Male 25 (65.8) 169 (67.1) 194 (66.9)  
 Unknown/missing  
Rai stage     
 Low, 0 2 (5.3) 9 (3.6) 11 (3.8) .496 
 Intermediate, I-II 23 (60.5) 136 (54.0) 159 (54.8)  
 High, III-IV 13 (34.2) 107 (42.5) 120 (41.4)  
 Unknown/missing  
ECOG PS     
 0 19 (50.0) 162 (64.3) 181 (62.4) .234 
 1 18 (47.4) 86 (34.1) 104 (35.9)  
 2 1 (2.6) 4 (1.6) 5 (1.7)  
 Unknown/missing  
Hemoglobin, g/dL     
 Mean (SD) 12.6 (2.5) 12.2 (2.1) 12.2 (2.2) .180 
 Median (Q1, Q3) 12.8 (11.2, 14.5) 12.3 (10.7, 13.8) 12.4 (10.7, 14.0)  
 [Min, max] [6.5, 16.0] [4.4, 17.5] [4.4, 17.5]  
 Freq. of missing  
Platelets, 103/μL     
 Mean (SD) 190.1 (85.7) 157.8 (68.6) 162.0 (71.7) .051 
 Median (Q1, Q3) 170.5 (117.5, 246.2) 152.0 (110.0, 197.5) 152.5 (110.2, 201.0)  
 [Min, max] [68.0, 356.0] [9.6, 508.0] [9.6, 508.0]  
 Freq. of missing  
WBC, 103/μL     
 Mean (SD) 88.4 (129.2) 109.8 (114.7) 107.0 (116.7) .016 
 Median (Q1, Q3) 27.2 (8.4, 109.0) 73.6 (23.7, 161.5) 63.2 (20.1, 156.5)  
 [Min, max] [4.7, 617.5] [1.6, 597.7] [1.6, 617.5]  
 Freq. of missing  
β2-Microglobulin, mg/L     
 Mean (SD) 3.8 (2.0) 4.0 (2.0) 3.9 (2.0) .443 
 Median (Q1, Q3) 3.3 (2.4, 4.5) 3.6 (2.5, 4.6) 3.6 (2.5, 4.6)  
 [Min, max] [1.3, 10.7] [1.4, 14.4] [1.3, 14.4]  
 Freq. of missing  
β2-Microglobulin, category*     
 Elevated 17 (44.7) 131 (52.4) 148 (51.4) .390 
 Normal 21 (55.3) 119 (47.6) 140 (48.6)  
 Unknown/missing  
Serum creatinine, mg/dL     
 Mean (SD) 96.5 (7.3) 96.5 (6.5) 96.5 (6.6) .658 
 Median (Q1, Q3) 95.0 (92.0, 97.1) 95.1 (92.2, 99.2) 95.1 (92.2, 98.9)  
 [Min, max] [88.1, 123.0] [86.2, 123.9] [86.2, 123.9]  
 Freq. of missing  
Coombs test     
 Negative 36 (97.3) 229 (93.5) 265 (94.0) .708 
 Positive 1 (2.7) 16 (6.5) 17 (6.0)  
 Unknown/missing  
Splenomegaly     
 No 30 (78.9) 151 (59.9) 181 (62.4) .030 
 Yes 8 (21.1) 101 (40.1) 109 (37.6)  
 Unknown/missing  
Lymphadenopathy     
 No 14 (36.8) 70 (27.8) 84 (29.0) .255 
 Yes 24 (63.2) 182 (72.2) 206 (71.0)  
 Unknown/missing  
Del(11q22.3)     
 Abnormal 5 (13.2) 62 (24.7) 67 (23.2) .149 
 Normal 33 (86.8) 189 (75.3) 222 (76.8)  
 Unknown/missing  
Dohner classification     
 Del(17p) 0 (0.0) 0 (0.0) 0 (0.0) .033 
 Del(11q22) 5 (13.2) 62 (24.6) 67 (23.1)  
 Trisomy 12 16 (42.1) 46 (18.3) 62 (21.4)  
 Normal 5 (13.2) 49 (19.4) 54 (18.6)  
 Del(13q) 10 (26.3) 84 (33.3) 94 (32.4)  
 Other 2 (5.3) 11 (4.4) 13 (4.5)  
 Unknown/missing  
IGHV     
 Mutated 13 (39.4) 49 (21.9) 62 (24.1) .047 
 Unmutated 20 (60.6) 175 (78.1) 195 (75.9)  
 Unknown/missing 28 33  
Time up and go, s§     
 Mean (SD) 8.1 (2.6) 8.7 (2.4) 8.6 (2.4) .097 
 Median (Q1, Q3) 8.0 (6.0, 9.8) 9.0 (7.0, 10.0) 9.0 (7.0, 10.0)  
 [Min, max] [4.0, 17.0] [2.0, 21.0] [2.0, 21.0]  
 Freq. of missing  
CIRS     
 Mean (SD) 2.2 (2.3) 1.9 (2.2) 2.0 (2.2) .580 
 Median (Q1, Q3) 2.0 (1.0, 2.8) 1.0 (0.0, 3.0) 2.0 (0.0, 3.0)  
 [Min, max] [0.0, 10.0] [0.0, 14.0] [0.0, 14.0]  
 Freq. of missing 28 36  
% CD19+CD5+ cells     
 Mean (SD) 59.6 (32.1) 78.5 (22.0) 76.0 (24.4) <.001 
 Median (Q1, Q3) 70.2 (31.1, 87.6) 87.8 (69.1, 95.3) 85.2 (62.8, 94.9)  
 [Min, max] [1.3, 97.6] [2.8, 99.3] [1.3, 99.3]  
 Freq. of missing  
% CD38+ cells     
 Mean (SD) 47.5 (37.3) 35.4 (32.9) 37.0 (33.7) .084 
 Median (Q1, Q3) 47.2 (8.2, 83.5) 25.4 (4.3, 61.8) 27.6 (4.4, 67.3)  
 [Min, max] [0.2, 99.9] [0.1, 99.7] [0.1, 99.9]  
 Freq. of missing  
%CD38+ cells, category     
 High (>30%) 23 (60.5) 114 (46.3) 137 (48.2) .118 
 Low (≤30%) 15 (39.5) 132 (53.7) 147 (51.8)  
 Unknown/missing  
% CD49d+ cells     
 Mean (SD) 74.5 (37.8) 43.2 (41.8) 47.4 (42.6) <.001 
 Median (Q1, Q3) 98.0 (44.6, 99.9) 35.5 (1.2, 88.7) 44.7 (1.5, 96.5)  
 [Min, max] [0.1,100.0] [0.1,100.0] [0.1,100.0]  
 Freq. of missing  
%CD49d+ cells, category     
 High (>30%) 31 (81.6) 124 (50.4) 155 (54.6) <.001 
 Low (≤30%) 7 (18.4) 122 (49.6) 129 (45.4)  
 Unknown/missing  
% ZAP-70+ cells     
 Mean (SD) 21.3 (22.7) 21.4 (21.8) 21.4 (21.9) .785 
 Median (Q1, Q3) 14.9 (2.5, 31.9) 13.0 (4.7, 32.0) 13.1 (4.3, 32.2)  
  [Min, max] [0.1, 83.6] [0.0, 93.3] [0.0, 93.3]  
 Freq. of missing  
%ZAP-70+ cells, category     
 High (>20%) 14 (36.8) 94 (38.4) 108 (38.2) 1.000 
 Low (≤20%) 24 (63.2) 151 (61.6) 175 (61.8)  
 Unknown/missing  
TK (U/L)     
 Mean (SD) 36.8 (47.3) 33.0 (37.6) 33.5 (38.9) 0.937 
 Median (Q1, Q3) 21.0 (10.0, 34.0) 21.5 (9.6, 44.4) 21.5 (9.6, 44.1)  
 [Min, max] [0.0, 207.0] [0.0, 348.0] [0.0, 348.0]  
 Freq. of missing  
Variable/categoryMRDMRD+TotalP
Patients, n 38 252 290 – 
Age     
 Mean (SD) 56.4 (7.0) 56.3 (7.4) 56.3 (7.3) .879 
 Median (Q1, Q3) 57.5 (54.0, 60.8) 57.0 (51.8, 62.0) 57.0 (52.0, 62.0)  
 [Min, max] [35.0, 67.0] [31.0, 70.0] [31.0, 70.0]  
 Freq. of missing  
Age, category     
 <60 25 (65.8) 157 (62.3) 182 (62.8) .723 
 ≥60 13 (34.2) 95 (37.7) 108 (37.2)  
 Unknown/missing  
Sex     
 Female 13 (34.2) 83 (32.9) 96 (33.1) .855 
 Male 25 (65.8) 169 (67.1) 194 (66.9)  
 Unknown/missing  
Rai stage     
 Low, 0 2 (5.3) 9 (3.6) 11 (3.8) .496 
 Intermediate, I-II 23 (60.5) 136 (54.0) 159 (54.8)  
 High, III-IV 13 (34.2) 107 (42.5) 120 (41.4)  
 Unknown/missing  
ECOG PS     
 0 19 (50.0) 162 (64.3) 181 (62.4) .234 
 1 18 (47.4) 86 (34.1) 104 (35.9)  
 2 1 (2.6) 4 (1.6) 5 (1.7)  
 Unknown/missing  
Hemoglobin, g/dL     
 Mean (SD) 12.6 (2.5) 12.2 (2.1) 12.2 (2.2) .180 
 Median (Q1, Q3) 12.8 (11.2, 14.5) 12.3 (10.7, 13.8) 12.4 (10.7, 14.0)  
 [Min, max] [6.5, 16.0] [4.4, 17.5] [4.4, 17.5]  
 Freq. of missing  
Platelets, 103/μL     
 Mean (SD) 190.1 (85.7) 157.8 (68.6) 162.0 (71.7) .051 
 Median (Q1, Q3) 170.5 (117.5, 246.2) 152.0 (110.0, 197.5) 152.5 (110.2, 201.0)  
 [Min, max] [68.0, 356.0] [9.6, 508.0] [9.6, 508.0]  
 Freq. of missing  
WBC, 103/μL     
 Mean (SD) 88.4 (129.2) 109.8 (114.7) 107.0 (116.7) .016 
 Median (Q1, Q3) 27.2 (8.4, 109.0) 73.6 (23.7, 161.5) 63.2 (20.1, 156.5)  
 [Min, max] [4.7, 617.5] [1.6, 597.7] [1.6, 617.5]  
 Freq. of missing  
β2-Microglobulin, mg/L     
 Mean (SD) 3.8 (2.0) 4.0 (2.0) 3.9 (2.0) .443 
 Median (Q1, Q3) 3.3 (2.4, 4.5) 3.6 (2.5, 4.6) 3.6 (2.5, 4.6)  
 [Min, max] [1.3, 10.7] [1.4, 14.4] [1.3, 14.4]  
 Freq. of missing  
β2-Microglobulin, category*     
 Elevated 17 (44.7) 131 (52.4) 148 (51.4) .390 
 Normal 21 (55.3) 119 (47.6) 140 (48.6)  
 Unknown/missing  
Serum creatinine, mg/dL     
 Mean (SD) 96.5 (7.3) 96.5 (6.5) 96.5 (6.6) .658 
 Median (Q1, Q3) 95.0 (92.0, 97.1) 95.1 (92.2, 99.2) 95.1 (92.2, 98.9)  
 [Min, max] [88.1, 123.0] [86.2, 123.9] [86.2, 123.9]  
 Freq. of missing  
Coombs test     
 Negative 36 (97.3) 229 (93.5) 265 (94.0) .708 
 Positive 1 (2.7) 16 (6.5) 17 (6.0)  
 Unknown/missing  
Splenomegaly     
 No 30 (78.9) 151 (59.9) 181 (62.4) .030 
 Yes 8 (21.1) 101 (40.1) 109 (37.6)  
 Unknown/missing  
Lymphadenopathy     
 No 14 (36.8) 70 (27.8) 84 (29.0) .255 
 Yes 24 (63.2) 182 (72.2) 206 (71.0)  
 Unknown/missing  
Del(11q22.3)     
 Abnormal 5 (13.2) 62 (24.7) 67 (23.2) .149 
 Normal 33 (86.8) 189 (75.3) 222 (76.8)  
 Unknown/missing  
Dohner classification     
 Del(17p) 0 (0.0) 0 (0.0) 0 (0.0) .033 
 Del(11q22) 5 (13.2) 62 (24.6) 67 (23.1)  
 Trisomy 12 16 (42.1) 46 (18.3) 62 (21.4)  
 Normal 5 (13.2) 49 (19.4) 54 (18.6)  
 Del(13q) 10 (26.3) 84 (33.3) 94 (32.4)  
 Other 2 (5.3) 11 (4.4) 13 (4.5)  
 Unknown/missing  
IGHV     
 Mutated 13 (39.4) 49 (21.9) 62 (24.1) .047 
 Unmutated 20 (60.6) 175 (78.1) 195 (75.9)  
 Unknown/missing 28 33  
Time up and go, s§     
 Mean (SD) 8.1 (2.6) 8.7 (2.4) 8.6 (2.4) .097 
 Median (Q1, Q3) 8.0 (6.0, 9.8) 9.0 (7.0, 10.0) 9.0 (7.0, 10.0)  
 [Min, max] [4.0, 17.0] [2.0, 21.0] [2.0, 21.0]  
 Freq. of missing  
CIRS     
 Mean (SD) 2.2 (2.3) 1.9 (2.2) 2.0 (2.2) .580 
 Median (Q1, Q3) 2.0 (1.0, 2.8) 1.0 (0.0, 3.0) 2.0 (0.0, 3.0)  
 [Min, max] [0.0, 10.0] [0.0, 14.0] [0.0, 14.0]  
 Freq. of missing 28 36  
% CD19+CD5+ cells     
 Mean (SD) 59.6 (32.1) 78.5 (22.0) 76.0 (24.4) <.001 
 Median (Q1, Q3) 70.2 (31.1, 87.6) 87.8 (69.1, 95.3) 85.2 (62.8, 94.9)  
 [Min, max] [1.3, 97.6] [2.8, 99.3] [1.3, 99.3]  
 Freq. of missing  
% CD38+ cells     
 Mean (SD) 47.5 (37.3) 35.4 (32.9) 37.0 (33.7) .084 
 Median (Q1, Q3) 47.2 (8.2, 83.5) 25.4 (4.3, 61.8) 27.6 (4.4, 67.3)  
 [Min, max] [0.2, 99.9] [0.1, 99.7] [0.1, 99.9]  
 Freq. of missing  
%CD38+ cells, category     
 High (>30%) 23 (60.5) 114 (46.3) 137 (48.2) .118 
 Low (≤30%) 15 (39.5) 132 (53.7) 147 (51.8)  
 Unknown/missing  
% CD49d+ cells     
 Mean (SD) 74.5 (37.8) 43.2 (41.8) 47.4 (42.6) <.001 
 Median (Q1, Q3) 98.0 (44.6, 99.9) 35.5 (1.2, 88.7) 44.7 (1.5, 96.5)  
 [Min, max] [0.1,100.0] [0.1,100.0] [0.1,100.0]  
 Freq. of missing  
%CD49d+ cells, category     
 High (>30%) 31 (81.6) 124 (50.4) 155 (54.6) <.001 
 Low (≤30%) 7 (18.4) 122 (49.6) 129 (45.4)  
 Unknown/missing  
% ZAP-70+ cells     
 Mean (SD) 21.3 (22.7) 21.4 (21.8) 21.4 (21.9) .785 
 Median (Q1, Q3) 14.9 (2.5, 31.9) 13.0 (4.7, 32.0) 13.1 (4.3, 32.2)  
  [Min, max] [0.1, 83.6] [0.0, 93.3] [0.0, 93.3]  
 Freq. of missing  
%ZAP-70+ cells, category     
 High (>20%) 14 (36.8) 94 (38.4) 108 (38.2) 1.000 
 Low (≤20%) 24 (63.2) 151 (61.6) 175 (61.8)  
 Unknown/missing  
TK (U/L)     
 Mean (SD) 36.8 (47.3) 33.0 (37.6) 33.5 (38.9) 0.937 
 Median (Q1, Q3) 21.0 (10.0, 34.0) 21.5 (9.6, 44.4) 21.5 (9.6, 44.1)  
 [Min, max] [0.0, 207.0] [0.0, 348.0] [0.0, 348.0]  
 Freq. of missing  

MRD undetectable indicates that patient had undetectable MRD at least once. Patients without MRD data are not included.

*

Elevated defined as values >3.5 mg/L.

Direct anti-globulin test.

Based on Döhner et al.34 

§

Timed up-and-go test.35,36

or Create an Account

Close Modal
Close Modal